Key statistics
On Tuesday, NextCure Inc (2US:STU) closed at 1.24, 33.55% above the 52 week low of 0.93 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.18 |
---|---|
High | 1.24 |
Low | 1.18 |
Bid | 1.22 |
Offer | 1.34 |
Previous close | 1.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 27.98m |
Free float | 25.49m |
P/E (TTM) | -- |
Market cap | 37.77m USD |
EPS (TTM) | -2.20 USD |
Data delayed at least 15 minutes, as of Oct 08 2024.
More ▼
Announcements
- NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
- NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
- NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
- NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
- NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
- NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
- NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
- NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
More ▼